Introducing Lecanemab, the Latest Alzheimer’s Disease Drug to Receive FDA Accelerated Approval
Host Nathaniel Chin, MD, gives an overview of the new Alzheimer’s treatment Leqembi (lecanemab), and highlights results from the second and third phases of its clinical trials. On January 6, 2023, the...
17 Jan 202320min
Healthy Habits for the New Year and Modifiable Risk Factors for Alzheimer’s Disease
Host Nathaniel Chin, MD, starts the new year by discussing modifiable risk factors for Alzheimer’s disease, commenting on building healthy lifestyle habits for the new year, and reflecting as Dementia...
10 Jan 202314min
Bioenergetics: How Mitochondria Affects Alzheimer’s Disease and Aging
It’s generally known that mitochondria are the powerhouse of cells, but did you know they can play a significant role in aging processes? Through the field of bioenergetics, scientists are looking to ...
29 Des 202225min
Looking Toward the Future: How Preclinical Alzheimer’s Disease Biomarker Disclosures Impact Society
The field of biomarkers is advancing quickly, allowing preclinical Alzheimer’s disease to be identified earlier and earlier in a person’s life. As individuals learn they are at risk for Alzheimer’s ye...
13 Des 202237min
Mixed Dementia, Explained
Though brain and cognitive changes are typically diagnosed as one form of dementia, recent studies have shown that mixed dementia is more common than previously thought. Mixed dementia, also known as ...
29 Nov 202228min
The Case for Disclosing Biomarker Results to Alzheimer’s Research Participants
Though several validated biomarkers are studied and used in Alzheimer’s disease research, most research participants don’t have the opportunity to learn their biomarker results afterward, even if they...
15 Nov 202239min
Promoting Open Science and Community Engagement with the National Institute on Aging
Dementia Matters Special Series: The National Strategy for Alzheimer's Disease Data and Research Part 6 Concluding our special series on the 2022 Spring ADRC Meeting, Dr. Cerise Elliott joins the podc...
1 Nov 202210min
Moving into the Digital Era of Alzheimer’s Disease Research
Dementia Matters Special Series: The National Strategy for Alzheimer's Disease Data and Research Part 5 Whether it be due to new research findings, innovative approaches and ideas, or technological ad...
25 Okt 202218min
